|

"I've
definitely noticed a difference since I started taking
Testicor. My erections are firmer and fuller and I just
feel more confident"
Studies on Yohimbe
(the active ingredient
in Testicor)
Yohimbe (also know as Pausinystalia
yohimbe), the active ingredient in Testicor, comes from
the bark of a West African tree that grows in Cameroon,
Congo and Gabon. Discovered in 1896, researchers performed
the first study in 1900 and discovered that Yohimbe
was an active excitant to sexual organs in both animal
and human studies.
A report in a letter to the American
Medical Association in 1981, that 4 out of 6 diabetic
patients were successfully treated with yohimbe for
impotence, stimulated new interest.
In 1984, an animal study on rats concluded
that yohimbe did increase the sexual arousal of animals.
In 1987 an experimental double blind
study of 100 men with organic erectile dysfunction resulted
in 43.5% of the men showing a positive response as reported
in Botanical Influences on Illness.
A more recent review of 16 different
studies, as documented in the March 1999 issue of Herbs
for Health, demonstrates that yohimbe is effective
for treatment of erection impairment by affecting the
autonomic nervous system and increasing blood flow to
the penis.
Another recent study in Ontario, Canada
also found yohimbe effective in restoring erectile function
in cases of psychogenic impotence (deriving from psychological
condition). Researchers at the department of Psychology,
Psychiatry, Urology and Pharmacy at the Kingston General
Hospital conducted a study of 48 patients. In a 10 week
placebo-controlled, double blind study, 46% reported
a positive response.
In a 1994 paper on "Yohimbine and the
Treatment of Erectile Disorder" in the May/June issue
of BJCP, It was noted that in America 52% of
men aged 40-70 years old have some degree of erectile
difficulty. The paper noted that it is now possible
to restore useable erection in 95% of men with erectile
difficulties. The paper also noted interestingly, that
originally yohimbine was administered intravenously
in a cardiovascular study and that volunteers taking
part in this study reported erections as a side effect.
|